Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
Not Confirmed
Not Confirmed
07-11 July, 2025
Not Confirmed
Not Confirmed
09-11 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Industry Trade Show
Not Confirmed
07-11 July, 2025
Industry Trade Show
Not Confirmed
09-11 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
30 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250628336756/en/Takeda-Announces-U.S.-FDA-Approval-of-GAMMAGARD-LIQUID-ERC-the-Only-Ready-to-Use-Liquid-Immunoglobulin-Therapy-with-Low-Immunoglobulin-A-IgA-Content1
25 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250623826419/en/Takeda-Announces-New-Assignments-of-Directors
03 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250603992751/en/European-Commission-Approves-ADCETRIS-brentuximab-vedotin-for-the-Treatment-of-Adult-Patients-with-Newly-Diagnosed-Stage-IIbIIIIV-Hodgkin-Lymphoma-in-Combination-with-ECADD
01 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250531031305/en/Protagonist-and-Takeda-Announce-ASCO-Plenary-Presentation-Highlighting-Full-32-Week-Results-from-Phase-3-VERIFY-Study-of-Rusfertide-Showing-Reductions-in-Phlebotomy-Improved-Hematocrit-Control-in-Polycythemia-Vera
27 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250527716937/en/Takeda-and-Nature-Announce-Call-for-Applications-Now-Open-for-2026-Innovators-in-Science-Award
14 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250508841747/en/The-New-England-Journal-of-Medicine-Publishes-Data-from-Phase-2b-Trial-of-Oral-Orexin-Receptor-2-Agonist-Oveporexton-TAK-861-in-People-with-Narcolepsy-Type-1
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5609
Submission : 1984-10-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3414
Submission : 1979-01-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2859
Submission : 1977-02-10
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2318
Submission : 1974-08-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7071
Submission : 1987-07-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10416
Submission : 1993-08-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16755
Submission : 2003-08-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7021
Submission : 1987-06-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4616
Submission : 1982-07-12
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6315
Submission : 1986-03-10
Status : Inactive
Type : II
NDC Package Code : 11532-1453
Start Marketing Date : 1993-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (15mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1452
Start Marketing Date : 1993-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (11.25mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-3662
Start Marketing Date : 1997-03-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (11.25mg/1.5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-3680
Start Marketing Date : 2010-08-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (30mg/1.5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1451
Start Marketing Date : 1989-01-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (7.5mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-3338
Start Marketing Date : 1995-12-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (22.5mg/1.5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1450
Start Marketing Date : 1990-10-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (3.75mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1457
Start Marketing Date : 2011-08-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (30mg/1.5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1456
Start Marketing Date : 2011-08-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (11.25mg/1.5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1454
Start Marketing Date : 1993-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (7.5mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
Regulatory Info :
Registration Country : Norway
Dosage Form : Solution for injection
Brand Name : Adrenalin
Dosage Strength : 0.1mg/ml
Packaging : Ampoule av glass 10 5ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Dosage Form : Solution for injection
Brand Name : Adrenalin
Dosage Strength : 1mg/ml
Packaging : Ampoule av glass 10 1ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Originator
Registration Country : South Africa
Dosage Form : INF
Brand Name : Replagal
Dosage Strength : 1mg/ml
Packaging : 3.5X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : REPLAGAL
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number : 2249057
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Switzerland
Dosage Form : Inf Conc
Brand Name : Replagal
Dosage Strength : 3.5mg/3.5ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Sweden
Dosage Form : TABLET
Brand Name : Allopurinol Nycomed
Dosage Strength : 100 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Dosage Form : Antic-calc Tablet
Brand Name : Allopur
Dosage Strength : 300 mg
Packaging : Box
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Sweden
Dosage Form : TABLET
Brand Name : Allopurinol Nycomed
Dosage Strength : 300 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Dosage Form : Antic-calc Tablet
Brand Name : Allopur
Dosage Strength : 100 mg
Packaging : Box
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Canada
ALOGLIPTIN (ALOGLIPTIN BENZOATE)
Dosage Form : TABLET
Brand Name : KAZANO
Dosage Strength : 12.5MG
Packaging : 60
Approval Date :
Application Number : 2417219
Regulatory Info :
Registration Country : Canada
Inspections and registrations
ABOUT THIS PAGE
TAKEDA is a supplier offers 37 products (APIs, Excipients or Intermediates).
Find a price of Leuprolide Acetate bulk with CEP offered by TAKEDA
Find a price of Pantoprazole Sodium bulk with CEP offered by TAKEDA
Find a price of Candesartan Cilexetil bulk with JDMF offered by TAKEDA
Find a price of Codeine bulk with JDMF offered by TAKEDA
Find a price of Codeine Phosphate bulk with JDMF offered by TAKEDA
Find a price of Leuprolide Acetate bulk with DMF offered by TAKEDA
Find a price of Morphine Hydrochloride bulk with JDMF offered by TAKEDA
Find a price of Noscapine bulk with JDMF offered by TAKEDA
Find a price of Ridaforolimus bulk with DMF offered by TAKEDA
Find a price of Succinylcholine Chloride bulk with CEP offered by TAKEDA
Find a price of Deproteinised hemoderivative of calf blood, Actovegin concentrate bulk with CEP offered by TAKEDA
Find a price of Azilsartan bulk offered by TAKEDA
Find a price of Cefmenoxime HCl bulk offered by TAKEDA
Find a price of Cefotiam bulk offered by TAKEDA
Find a price of Cefsulodin bulk offered by TAKEDA
Find a price of Estazolam bulk offered by TAKEDA
Find a price of Folic Acid bulk offered by TAKEDA
Find a price of Hydromorphone Hydrochloride bulk offered by TAKEDA
Find a price of Leuprolide Acetate bulk offered by TAKEDA
Find a price of O-Chloroacetylcarbamoyl-Fumagillol bulk offered by TAKEDA
Find a price of Oxendolone bulk offered by TAKEDA
Find a price of Pyridoxine Hydrochloride bulk offered by TAKEDA
Find a price of Sodium Carbonate bulk offered by TAKEDA
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN SHONAN PLANT. bulk offered by TAKEDA
Find a price of TAK-603 bulk offered by TAKEDA
Find a price of TAP-144-SR(N) 7.5 AND 3.75 MG. bulk offered by TAKEDA
Find a price of SODIUM DEACETYL CEPHALOSPORIN C (DCPE-Na) PRODUCTION IN HIKARI PLANT bulk offered by TAKEDA
Find a price of EM574 bulk offered by TAKEDA
Find a price of PROCESSING OF OXENDOLONE AQUOSUSPENSOID INJ IN THE OSAKA PLANT bulk offered by TAKEDA
Find a price of FACILITIES AND OPERATING PROCEDURES IN HIKARI-CITY, YAMAGUCHI, JAPAN bulk offered by TAKEDA
Find a price of Alogliptin Benzoate bulk offered by TAKEDA
Find a price of Dexlansoprazole bulk offered by TAKEDA
Find a price of Lansoprazole bulk offered by TAKEDA
Find a price of Pioglitazone Hydrochloride bulk offered by TAKEDA
Find a price of Roflumilast bulk offered by TAKEDA
Find a price of Vedolizumab bulk offered by TAKEDA
Find a price of Vonoprazan Fumarate bulk offered by TAKEDA